People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Theraclion | — | Biotechnology | Pre-Seed | $250K | $13.8M | 2015 |
Jean-Yves Burel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jean-Yves Burel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michel Nuta | 1 | 1 |
| Bern Von Polheim | 1 | 1 |
| Sarah Ankri | 1 | 1 |
| Laurent Levy | 1 | 1 |
| Sylvain Yon | 1 | 1 |
| Francois LaCoste | 1 | 1 |
| Anja Kleber | 1 | 1 |
| David Caumartin | 1 | 1 |
| Phillippe Pouletty | 1 | 1 |
| Vincent Gardes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.